Skyrizi 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FXAGU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $177,525
Award facts
- Contract value 100% obligated
- $177,524.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On September 18, 2025, the Defense Logistics Agency awarded a delivery order valued at $177,524.56 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml syringes. The contract utilizes a firm fixed price structure with no set-aside designation, indicating competitive award among qualified vendors. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
The contract supports the Defense Health Agency and other federal healthcare systems' pharmaceutical procurement needs. SKYRIZI is a biologic treatment used in dermatological and immunological applications, representing the type of specialty pharmaceutical products that AmerisourceBergen supplies through its extensive federal medical supply chain partnerships. The delivery order is scheduled for completion by September 19, 2025, fulfilling urgent medical supply requirements for military and defense healthcare operations. As a non-set-aside award, this delivery order reflects AmerisourceBergen's demonstrated capability to compete effectively for federal pharmaceutical procurement across its broad portfolio of brand-name and generic medications serving defense healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FXAGU?
SPE2DB25FXAGU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FXAGU worth?
The government has obligated $177,525 on SPE2DB25FXAGU.
Is contract SPE2DB25FXAGU an order under another contract?
Yes. SPE2DB25FXAGU is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FXAGU competed?
The extent of competition for SPE2DB25FXAGU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award